CUSTOMER SUPPORT CUSTOMER SUPPORT 022-4603 7236

fund search

Individually analyse each scheme and narrow your options further Every minute detail you need to know about scheme of your choice from asset holdings, best and worst performance and fund returns to competitor analysis; is available in the Fund card.
Using this report card, you can gather vital information regarding the future health of the scheme by analysing the top 10 companies and sectors it invests in. You can also track the fund management’s track record and analyse the philosophy behind scheme’s holdings. All the parameters in the fund card are extremely important and can go a long way in helping you decide which scheme to invest your money.

NAV As on Dec-20-2024

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)-Direct Plan

Top 10 Holdings
Company
(%)
Sun Pharmaceutical Industries Ltd.
13.77
Dr. Reddy's Laboratories Ltd.
8.48
Cipla Ltd.
7.94
Aurobindo Pharma Ltd.
5.04
Gland Pharma Ltd.
4.38
Lupin Ltd.
4.29
Alkem Laboratories Ltd.
4.16
Zydus Lifesciences Ltd.
3.10
Apollo Hospitals Enterprise Ltd.
2.93
Biocon Ltd.
2.39
Top 10 Sectors
Sectors
(%)
Pharmaceuticals & Drugs
75.75
Hospital & Healthcare Services
13.30
Business Support
4.70
Insurance
2.40
Chemicals
1.12
Asset Allocation
Market Cap Allocation
  Scheme Benchmark ()
Large-Cap 40.27 NA
Mid-Cap 24.96 NA
Small-Cap 29.36 NA

Best and Worst Performance and Ratios

Best Performance in a year
Period Fund (%) Benchmark (%)
Year 23/03/20
to 23/03/21
94.27NA
Worst Performance in a year
Period Fund (%) Benchmark (%)
Year 16/09/21
to 16/09/22
-12.32NA
Ratios
Standard Deviation[%] 15.31
Sharpe Ratio [%] 0.95
Turnover Ratio [%] 0.91
Modified Duration
YTM
Riskometer
very high risk

Investors understand that their principal will be at very high risk

Fund Details
Category
Sector Funds
Inception Date (Regular Plan)
13-Jul-18
Inception Date (Direct Plan)
13-Jul-18
Expense Ratio (Direct Plan) %
1.09
Expense Ratio (Regular Plan) %
1.92
Investing Style
Large Growth
Fund Manager
Dharmesh Kakkad
Scheme Benchmark
BSE HEALTH CARE - TRI
AUM (Rs. in Cr.)
5,044.63
Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Growth Chart of the Scheme Versus Benchmark (SIP value Rs10,000)
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)-Direct Plan BSE Health Care - TRI

Performance Comparison with similar Schemes and Benchmark